Approval · Notice of Compliance 27479 · 2022
FROVA: Notice of Compliance 27479
Issued January 26, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27479
- Date
- January 26, 2022
- Company
- Endo Pharmaceuticals Inc
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Addition of a manufacturing site for the drug substance starting material.
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| FROVA | Not yet assigned | — |
Medicinal ingredients
- FROVATRIPTAN SUCCINATE 2.5 MG per TAB